
How do I evaluate what you're actually buying — in the aisle that sells 'bladder control' next to the cranberry?
The urinary aisle has two faces: the infection-prevention shelf our UTI page graded (PAC capsules, D-mannose powder, strain-named probiotics — dose-and-strain literacy), and the control-products shelf — 'bladder control' capsules, pumpkin-seed and soy-germ blends, and 'urinary tract cleanse' teas — whose best evidence is small trials from single research regions, and whose worst is the borrowed-claim formula entirely. The honest shelf is narrow: three products with mechanisms and label requirements, one safety line the aisle never prints (nothing here treats an active infection or a control disorder), and one grading rule for the control category (interesting-but-unreplicated is Tier 3, not Top Pick).
36 mg standardized — the studied dose
Grams counted — the honest dose format
GR-1/RC-14 or nothing
The category this chapter retires
The studied intervention: capsules standardized to proanthocyanidin content, dosed to 36 mg daily — the amount the anti-adhesion evidence supports. The label must state PAC content (often via BL-DMAC method); 'cranberry 500 mg' without a PAC number is content, not dose — our UTI page's rule, unchanged on this shelf.
The folklore format: typical servings deliver a fraction of the studied PACs with a sugar load attached. The juice is tradition; the capsule is the trial — and nothing about this organ's wall is improved by the glucose.
Label literacy in the urinary aisle has four specific jobs:
The bladder market sells to the embarrassed — the population least likely to ask their doctor. Be highly cautious of products that: